Immune checkpoint inhibitor retreatment in second-line treatment of esophageal cancer: A real-world study.

被引：0
|
作者：
Kang, Yixin
Zhang, Dianbao
Mi, Youjia
Niu, Xiedong
Kang, Yuan
Xie, Dongjie
Li, Wenyao
Zhang, Ce
Yang, Junqiang
Yao, Jun
机构：
[1] Henan Univ Sci & Technol, Affiliated Hosp 1, Luoyang, Peoples R China
[2] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Gastroenterol Oncol, Luoyang, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16034
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study
    Rizzo, Alessandro
    Salati, Massimiliano
    Frega, Giorgio
    Merz, Valeria
    Caputo, Francesco
    Di Federico, Alessandro
    Palloni, Andrea
    Carloni, Riccardo
    Ricci, Angela Dalia
    Gadaleta-Caldarola, Gennaro
    Messina, Carlo
    Spallanzani, Andrea
    Gelsomino, Fabio
    Benatti, Stefania
    Luppi, Gabriele
    Melisi, Davide
    Dominici, Massimo
    Brandi, Giovanni
    MEDICINA-LITHUANIA, 2022, 58 (11):
  • [22] EFfectiveness and Safety Profile of Lurbinectedin in Second-Line Small Cell Lung Cancer: A Real-World Study
    Ganti, A. K.
    Allan, V.
    Merola, D.
    Estrin, A.
    Boccuti, A.
    Rengarajan, B.
    Baratta, C.
    Prince, P.
    Li, W.
    Cao, Y.
    D'Agostino, R. B., Jr.
    Poole, E. M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S378 - S379
  • [23] Real-world outcomes upon second-line treatment in patients with chronic lymphocytic leukaemia
    Vainer, Noomi
    Aarup, Kathrine
    Andersen, Michael Asger
    Wind-Hansen, Lise
    Nielsen, Tine
    Frederiksen, Henrik
    Enggaard, Lisbeth
    Poulsen, Christian Bjorn
    Niemann, Carsten U.
    Rotbain, Emelie C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (05) : 874 - 886
  • [24] Second-line metastatic urothelial carcinoma treatment and survival in real-world patients in the US
    Pal, S. K.
    Galsky, M. D.
    Lin, S-W.
    Ogale, S.
    Zivkovic, M.
    Simpson, J.
    Derleth, C.
    Sonpavde, G.
    ANNALS OF ONCOLOGY, 2016, 27
  • [25] The real-world data of immune-checkpoint inhibitor combination therapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study
    Sato, Sho
    Ssuzuki, Takashi
    Chinen, Takashi
    Yamaguchi, Hironori
    Suzuki, Yusuke
    Hokamura, Nobukazu
    Saze, Zenichiro
    Kono, Koji
    Takahashi, Keita
    Yano, Fumiaki
    Kunisaki, Chikara
    Kosaka, Takashi
    Endo, Itaru
    Ichikawa, Yasushi
    Miyawaki, Yutaka
    Sato, Hiroshi
    Shimada, Hideaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, : 994 - 1001
  • [26] Regorafenib monotherapy or combined with an immune-checkpoint inhibitor as later-line treatment for metastatic colorectal cancer: a multicenter, real-world retrospective study in China
    Qu, Wang
    Liu, Zimin
    Chen, Xiaobing
    Liu, Bo
    Zhao, Yunbo
    Yan, Hao
    Qu, Xiujuan
    Li, Shengmian
    Zang, Aimin
    Sun, Yongkun
    Zhu, Liangjun
    Zhou, Aiping
    BMC CANCER, 2024, 24 (01)
  • [27] Regorafenib monotherapy or combined with an immune-checkpoint inhibitor as later-line treatment for metastatic colorectal cancer: a multicenter, real-world retrospective study in China
    Wang Qu
    Zimin Liu
    Xiaobing Chen
    Bo Liu
    YunBo Zhao
    Hao Yan
    Xiujuan Qu
    Shengmian Li
    Aimin Zang
    Yongkun Sun
    Liangjun Zhu
    Aiping Zhou
    BMC Cancer, 24
  • [28] Efficacy and safety of regorafenib alone or in combinations in the second-line setting for advanced hepatocellular carcinoma: A multicenter real-world study.
    Zhang, Wei
    Zhao, Yanrong
    Ma, Guixiang
    Zhang, Yu
    Guo, Yuan
    Chen, Zhong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] Efficacy and safety of second-line regorafenib after sorafenib or lenvatinib first line in patients with unresectable hepatocellular carcinoma: A real-world study.
    Xue, Feng
    Zhai, Jian
    Liu, Jianwei
    Fu, Zhigang
    Sun, Yanfu
    Ge, Ruiliang
    Bai, Shilei
    Li, Xiaowei
    Wang, Kui
    Qu, Zengqiang
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16125 - E16125
  • [30] Primary pericardial mesothelioma: a case report of a patient treated with an immune checkpoint inhibitor as the second-line treatment
    Arponen, Otso
    Salo, Virpi
    Lonnberg, Annika
    Vaalavirta, Leila
    Koivu, Hannu
    Nyandoto, Paul
    ACTA ONCOLOGICA, 2021, 60 (05) : 687 - 691
12345